Innovation
Legal Barriers to the Better Use of Health Data to Deliver Pharmaceutical Innovation
1 December 2018
The proliferation of health data in our ever more digitalised world of health care creates opportunities for better research around – and delivery of – pharmaceutical…
Private Provision of Publicly Funded Health Care: The Economics of Ownership
1 September 2018
This OHE Briefing outlines the NHS ownership debate through the lens of economics. The aim of the Briefing is to improve understanding of how economics can…
The Impact of New Medicines in the NHS: 70 Years of Innovation
1 August 2018
In 2018, the NHS turns 70. This OHE Consulting Report demonstrates the contribution and impact of medicines to the health economy in the UK throughout the…
Economics of Innovative Payment Models Compared with Single Pricing of Pharmaceuticals
1 July 2018
The current system of a single price per medicine means that, for multi-indication medicines, the relationship between price and “value” can vary substantially. In this OHE…
R&D, Competition and Diffusion of Innovation in the EU: The Case of Hepatitis C
1 July 2018
Using a multidisciplinary methodological approach combining a theoretical economic framework with uptake/market share analyses by country and interviews, this OHE research concludes that: (i) IP incentives…
Public Health and Economic Implications of the United Kingdom Exiting the EU and the Single Market
12 December 2017
This report explores the consequences of the exit of the United Kingdom (UK) from the European Union (EU) on public health in the UK and in…
OHE Lunchtime Seminar: The UK Biotech Sector and Brexit: Past Performance and Future Prospects
25 September 2017
OHE Lunchtime Seminar with Sir Geoffrey Owen and Professor Michael Hopkins. The biotech sector of the US has enjoyed a success that the UK sector has…
An Insurance Framework for Funding New Antibiotics
22 September 2017
A new paper sets out an insurance model as part of a global solution to incentivise R&D for new antibiotics to tackle multi-drug resistance. It offers…
OHE Lunchtime Seminar: How Cost-Effective are New Cancer Drugs in the U.S.?
2 August 2017
On Tuesday 19th September 2017, Professor Frank Lichtenberg from Columbia University will lead an OHE Lunchtime Seminar on the topic of: How cost-effective are new cancer…